| 1.2 |
3.6 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.8 |
2.4 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.6 |
3.5 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.5 |
2.1 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.5 |
1.5 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.5 |
1.4 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.4 |
1.8 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.4 |
1.7 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.4 |
2.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.4 |
1.2 |
GO:0097402 |
neuroblast differentiation(GO:0014016) neuroblast migration(GO:0097402) |
| 0.4 |
3.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.3 |
1.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.3 |
2.2 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.3 |
0.8 |
GO:1902915 |
negative regulation of protein import into nucleus, translocation(GO:0033159) protein poly-ADP-ribosylation(GO:0070212) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 |
0.7 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.2 |
4.2 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 |
1.1 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
0.4 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.2 |
1.5 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 |
0.8 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
1.3 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.2 |
0.9 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.2 |
0.9 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
0.4 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.2 |
1.7 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
1.3 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
1.0 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
1.0 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.1 |
1.3 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
4.4 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.4 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.1 |
0.7 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.9 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
0.3 |
GO:1903225 |
regulation of endodermal cell fate specification(GO:0042663) negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.3 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 |
0.7 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.8 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
1.8 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.5 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
1.2 |
GO:0019243 |
glutathione biosynthetic process(GO:0006750) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
1.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.1 |
0.4 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
1.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.5 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.3 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.2 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.5 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.2 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.0 |
0.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.3 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
1.0 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.4 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) negative regulation of protein folding(GO:1903333) |
| 0.0 |
2.9 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.0 |
0.2 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
2.8 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
1.5 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 |
0.1 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 |
0.1 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.2 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
1.2 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.1 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.0 |
0.4 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 |
3.9 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.0 |
0.9 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.3 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.5 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.6 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
1.9 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
1.1 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.4 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.5 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
